Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2025-12-31 @ 10:08 PM
Study NCT ID:
NCT05091333
Status:
COMPLETED
Last Update Posted:
2025-05-14
First Post:
2021-09-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
FASENRA Regulatory Postmarketing Surveillance in Korea
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-11
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-03-06
Completion Date Type:
ACTUAL
First Submit Date:
2021-09-30
First Submit QC Date:
None
Study First Post Date:
2021-10-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-13
Last Update Post Date:
2025-05-14
Last Update Post Date Type:
ACTUAL